ReviewFrontiers in immunology2026

Beyond combination: sequencing priming modalities before immune checkpoint inhibitors to convert immunologically cold tumors toward an ICI-responsive phenotype.

Weiqiang Fan et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.